In Silico & Data InsightsRegulatory SubmissionStudy Management
The Journey of a Molecule – CMC Readiness
Instem Team
Ensuring Quality, Traceability, and Compliance
In Silico & Data Insights Blog
In Silico & Data InsightsRegulatory SubmissionStudy Management
The Journey of a Molecule – Toxicology
Instem Team
Accelerating Preclinical Safety with Connected Data and Predictive Insights
In Silico & Data InsightsRegulatory SubmissionStudy Management
The Journey of a Molecule – Preclinical Efficacy
Instem Team
Enhancing Study Quality and Data Integrity in the Preclinical Phase
In Silico & Data InsightsLeadscopePress Releases
INSTEM Announces Extension of Research Collaboration Agreement with U.S. FDA to 2031
Mike Thurogood, CMktr
Instem, a global leader in SaaS solutions for life sciences R&D, today announced a 5-year extension of its Research Collaboration Agreement (RCA) with the U.S. Food and Drug Administration (FDA).
In Silico & Data InsightsRegulatory SubmissionStudy Management
The Journey of a Molecule – Lead Optimization
Instem Team
Unifying Science and Safety to Navigate the Iterative Path of Lead Optimization
In Silico & Data InsightsRegulatory SubmissionStudy Management
The Journey of a Molecule – Discovery
Instem Team
Discover how Instem’s Advance™, Predict™, and BioRails® accelerate early-stage drug discovery by unifying in silico insights, experimental data, and streamlined workflows.
Stay up to Date
Get expert tips, industry news, and fresh content delivered to your inbox.
